Clinical Trial Update: Bevacizumab in Patients With Severe Covid-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating bevacizumab for patients with severe COVID-19 pneumonia; status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN